Shenzhen Kangtai Biological Products Co.,Ltd.’s Net Profit Dropped 80.4% in First Three Quarters of 2022
Listen to the full version

Shenzhen Kangtai Biological Products Co.,Ltd. (深圳康泰生物制品股份有限公司) (300601.SZ) reported a net profit of 203.1 million yuan in the first three quarters of 2022, down 80.4% year-on-year.
Meanwhile, the company posted 2.6 billion yuan in revenue, up 7.9% year-on-year.
At the end of the reporting period, it had 13.9 billion yuan in total assets and 4.6 billion yuan in total liabilities, with a liability-to-asset ratio of 32.9%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR